A prospective clinical, cost and environmental analysis of a clinician-led urology virtual clinic

Abstract

INTRODUCTION A virtual clinic is a form of telemedicine where contact between clinical teams and patients occur without face-toface consultation. Our study aims to quantify the clinical, financial and environmental benefits of our virtual urology clinic. MATERIAL AND METHODS We collected data prospectively from our weekly follow-up virtual clinic over a continuous four-month period between July and September 2017. RESULTS In total, we reviewed 409 patients. Following virtual clinic consultation, 68.5% of our patients were discharged from further follow-up. The majority of our patients (male 57.7%, female 55.5%) were of working age. The satisfaction scores were high, at 90.1%, and there were no reported adverse events as a result of using the virtual clinic. Our calculated cost savings were £18,744, with a predicted 12-month cost saving of £56,232. The creation of additional face-to-face clinic capacity has created an estimated 12-month increase in tariff generation for our unit of £72,072. In total, 4623 travel miles were avoided by patients using the virtual clinic, with an estimated avoided carbon footprint of 0.35-1.45 metric tonnes of CO 2e , depending on mode of transport. Our predicted 12-month avoided carbon footprint is 1.04-4.04 metric tonnes of CO 2e. CONCLUSIONS Our virtual clinic model has demonstrated a trifecta of positive outcomes, namely, clinical, financial and environmental benefits. The environmental importance and benefits of a virtual clinic should be promoted as a social enterprise value when engaging stakeholders in setting up such a urological service. We propose the adoption of our virtual clinic model in those urological units considering this method of telemedicine.

COVID‐19 pandemic – is virtual urology clinic the answer to keeping the cancer pathway moving?

“…Virtual clinic is a form of telemedicine between healthcare professionals and patients that crucially occurs without the need for a traditional face‐to‐face consultation and thus avoids in‐person attendance at hospital [1]. Our group has previously published two large prospective studies confirming clinical equivalency, safety and acceptable patient satisfaction in both prostate cancer and the endourology setting [4,5].…”

“Tele-Urology”: Is the COVID-19 Pandemic a Wake-up Call?

“…Many studies revealed that telemedicine is safe, equivalent to face-to-face consultations, time-saving, and likely to be cost-effective [15,22]. It could be utilized in screenings or for follow-up visits which do not require physical examination [23].…”

Implementation of an innovative surgical pharmacy service to improve patient outcomes—Twelve‐month outcomes of the Enhanced Surgical Medicines Optimization Service

“…The primary outcome was the actual length of stay (ALOS), which was calculated as the continuous time‐period (days) of each inpatient spell. The nationally expected length of stay (ELOS) for corresponding major elective surgical procedures was also retrieved and compared with each patient's ALOS.…”

“…During the preoperative phase, patients are reviewed in a virtual pharmacist clinic whereby patients' pre‐existing medical co‐morbidities are recorded by pharmacists along with any high‐risk medication the patient is taking . In the post‐operative phase, all patients are closely monitored on the ward with the focus being on medicines optimization to minimize the incidence of any post‐operative complications occurring.…”